Brian Silver Selected Research

3- (4- (2- hydroxyethyl)piperazin- 1- yl)- 7- (6- methoxypyridin- 3- yl)- 1- (2- propoxyethyl)pyrido(3,4- b)pyrazin- 2(1H)- one

9/2016

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian Silver Research Topics

Disease

38	Stroke (Strokes) 07/2023 - 01/2002
24	Ischemic Stroke 04/2023 - 12/2003
7	Atrial Fibrillation 06/2017 - 11/2011
5	Infarction (Infarctions) 06/2019 - 05/2006
5	Cerebral Hemorrhage 01/2019 - 05/2006
4	Carotid Stenosis (Carotid Artery Stenosis) 01/2016 - 10/2010
3	Hemorrhagic Stroke 01/2022 - 10/2014
2	Hypertension (High Blood Pressure) 10/2019 - 10/2014
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 12/2003
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2018 - 07/2016
2	Embolic Stroke 06/2017 - 11/2006
2	Neurologic Manifestations (Neurological Manifestations) 08/2016 - 11/2011
1	COVID-19 01/2023
1	Thrombotic Thrombocytopenic Purpura 01/2022
1	Neoplasms (Cancer) 01/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Dementia (Dementias) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Pneumonia (Pneumonitis) 02/2020
1	Myocardial Infarction 01/2020
1	Myxoma (Myxomas) 10/2019
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2019
1	Diabetes Mellitus 10/2019
1	Hyperlipidemias (Hyperlipidemia) 10/2019
1	Hematoma 01/2019
1	Hypoalbuminemia 10/2017
1	Alcoholism (Alcohol Abuse) 11/2016
1	Headache (Headaches) 07/2016
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 05/2014
1	Venous Thromboembolism 05/2014
1	Angioedema 07/2011
1	Transient Ischemic Attack 08/2008

Drug/Important Bio-Agent (IBA)

9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 01/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 04/2009
3	AnticoagulantsIBA 01/2023 - 05/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2009
3	TroponinIBA 01/2020 - 11/2011
3	Sildenafil Citrate (Viagra)FDA Link 09/2009 - 05/2006
2	omega-Chloroacetophenone (Mace)IBA 06/2023 - 01/2020
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020 - 05/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2016 - 05/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2013 - 11/2011
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 11/2006 - 05/2006
2	Abciximab (ReoPro)FDA Link 01/2004 - 12/2003
1	DisintegrinsIBA 01/2022
1	ThrombospondinsIBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Dietary CholesterolIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 10/2019
1	Vitamin K FDA Link 01/2019
1	A 19IBA 01/2018
1	AlbuminsIBA 10/2017
1	Serum AlbuminIBA 10/2017
1	Nicotine FDA Link 11/2016
1	3- (4- (2- hydroxyethyl)piperazin- 1- yl)- 7- (6- methoxypyridin- 3- yl)- 1- (2- propoxyethyl)pyrido(3,4- b)pyrazin- 2(1H)- oneIBA 09/2016
1	MagnesiumIBA 07/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2016
1	Tenecteplase FDA Link 06/2015
1	PotassiumIBA 10/2014
1	Dietary PotassiumIBA 10/2014
1	LDL CholesterolIBA 05/2014
1	Heparinoids (Heparinoid)IBA 05/2014
1	Heparin (Liquaemin)FDA LinkGeneric 05/2014
1	VitaminsIBA 05/2014
1	Type A Botulinum Toxins (Botox)FDA Link 05/2014
1	Clopidogrel (Plavix)FDA Link 12/2013
1	Dipyridamole (Persantine)FDA LinkGeneric 12/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2009
1	HDL LipoproteinsIBA 04/2009
1	LipidsIBA 04/2009
1	antineoplaston A10 (A 10)IBA 08/2008

Therapy/Procedure

12	Therapeutics 04/2023 - 01/2008
5	Thrombectomy 04/2023 - 04/2018
5	Length of Stay 01/2023 - 04/2017
3	Thrombolytic Therapy 12/2020 - 10/2004
2	Bed Rest (Bedrest) 04/2023 - 02/2020
2	Patient Readmission 01/2023 - 01/2022
2	Aftercare (After-Treatment) 08/2016 - 10/2004
1	Palliative Care (Palliative Therapy) 07/2023
1	Early Ambulation 04/2023
1	Precision Medicine 01/2022
1	Subacute Care 01/2022
1	Cardiopulmonary Resuscitation (CPR) 08/2018
1	Resuscitation 08/2018
1	Embolectomy 04/2018
1	Critical Care (Surgical Intensive Care) 01/2015
1	Patient Handoff 07/2014
1	Compression Stockings 05/2014
1	Surgical Decompression 05/2014
1	Duration of Therapy 05/2014
1	Intermittent Pneumatic Compression Devices 05/2014
1	Secondary Prevention 05/2014
1	Plasmapheresis 11/2011
1	Endarterectomy (Thromboendarterectomy) 10/2010